{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:44:38Z","timestamp":1782996278392,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["113416"],"award-info":[{"award-number":["113416"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20049"],"award-info":[{"award-number":["20049"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1003-y","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T08:04:43Z","timestamp":1548749083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravis"],"prefix":"10.1186","volume":"14","author":[{"given":"Melissa","family":"Nel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8999-718X","authenticated-orcid":false,"given":"Jeannine M.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"1003_CR1","doi-asserted-by":"crossref","unstructured":"Rautenbach RM, Pillay K, Murray ADN, Heckmann JM. Extraocular muscle findings in myasthenia gravis associated treatment-resistant Ophthalmoplegia. J Neuro-Ophthalmology. 2017;37:414\u20137.","DOI":"10.1097\/WNO.0000000000000534"},{"key":"1003_CR2","doi-asserted-by":"crossref","unstructured":"Europa TA, Nel M, Heckmann JM. Myasthenic ophthalmoparesis: time to resolution after initiating immune therapies. Muscle Nerve. 2018;58:542\u20139.","DOI":"10.1002\/mus.26172"},{"key":"1003_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1196\/annals.1405.037","volume":"1132","author":"J Soltys","year":"2008","unstructured":"Soltys J, Gong B, Kaminski HJ, Zhou Y, Kusner LL. Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment? Ann N Y Acad Sci. 2008;1132:220\u20134.","journal-title":"Ann N Y Acad Sci"},{"key":"1003_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/mus.24348","volume":"51","author":"B Mombaur","year":"2015","unstructured":"Mombaur B, Lesosky MR, Liebenberg L, Vreede H, Heckmann JM. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa. Muscle Nerve. 2015;51:533\u20137.","journal-title":"Muscle Nerve"},{"key":"1003_CR5","doi-asserted-by":"crossref","unstructured":"Heckmann JM, Nel M. A unique subphenotype of myasthenia gravis. Ann N Y Acad Sci. 2018;1412:14\u201320.","DOI":"10.1111\/nyas.13471"},{"key":"1003_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.7196\/SAMJ.5390","volume":"102","author":"JM Heckmann","year":"2012","unstructured":"Heckmann JM, Hansen P, Van Toorn R, Lubbe E, Janse van Rensburg E, Wilmshurst JM. The characteristics of juvenile myasthenia gravis among south Africans. South African Med J. 2012;102:532\u20136.","journal-title":"South African Med J"},{"key":"1003_CR7","first-page":"1","volume":"11","author":"JM Heckmann","year":"2010","unstructured":"Heckmann JM, Uwimpuhwe H, Ballo R, Kaur M, Bajic VB, Prince S. A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis. Genes Immun Nature Publishing Group. 2010;11:1\u201310.","journal-title":"Genes Immun Nature Publishing Group"},{"key":"1003_CR8","first-page":"307","volume":"61","author":"M Nel","year":"2016","unstructured":"Nel M, Buys J, Rautenbach R, Mowla S, Prince S, Heckmann JM. The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis. J Hum Genet Nature Publishing Group. 2016;61:307\u201316.","journal-title":"J Hum Genet Nature Publishing Group"},{"key":"1003_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1076\/ceyr.23.2.86.5478","volume":"23","author":"ET Cocuzzi","year":"2001","unstructured":"Cocuzzi ET, Bardenstein DS, Stavitsky A, Sundarraj N, Medof ME. Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-beta and TNF-alpha. Curr Eye Res. 2001;23:86\u201392.","journal-title":"Curr Eye Res"},{"key":"1003_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.nmd.2017.06.009","volume":"27","author":"M Nel","year":"2017","unstructured":"Nel M, Jalali Sefid Dashti M, Gamieldien J, Heckmann JM. Exome sequencing identifies targets in the treatment-resistant ophthalmoplegic subphenotype of myasthenia gravis. Neuromuscul Disord. 2017;27:816\u201325.","journal-title":"Neuromuscul Disord"},{"key":"1003_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1152\/physiolgenomics.00158.2004","volume":"22","author":"MD Fischer","year":"2005","unstructured":"Fischer MD, Budak MT, Bakay M, Gorospe JR, Kjellgren D, Pedrosa-Domell\u00f6f F, et al. Definition of the unique human extraocular muscle allotype by expression profiling. Physiol Genomics. 2005;22:283\u201391.","journal-title":"Physiol Genomics"},{"key":"1003_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.mam.2005.12.003","volume":"27","author":"S Fleige","year":"2006","unstructured":"Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Asp Med. 2006;27:126\u201339.","journal-title":"Mol Asp Med"},{"key":"1003_CR13","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1167\/iovs.14-14422","volume":"55","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Kaminski HJ, Gong B, Cheng G, Feuerman JM, Kusner L. RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment. Investig Ophthalmol Vis Sci. 2014;55:4348\u201359.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1003_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fphys.2016.00524","volume":"7","author":"HJ Kaminski","year":"2016","unstructured":"Kaminski HJ, Himuro K, Alshaikh J, Gong B, Cheng G, Kusner LL. Differential RNA expression profile of skeletal muscle induced by experimental autoimmune myasthenia gravis in rats. Front Physiol. 2016;7:524.","journal-title":"Front Physiol"},{"key":"1003_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611\u201322.","journal-title":"Clin Chem"},{"key":"1003_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2199-10-66","volume":"10","author":"J Stern-Straeter","year":"2009","unstructured":"Stern-Straeter J, G a B, H\u00f6rmann K, Kinscherf R, Goessler UR. Identification of valid reference genes during the differentiation of human myoblasts. BMC Mol Biol. 2009;10:66.","journal-title":"BMC Mol Biol"},{"key":"1003_CR17","unstructured":"Hildyard JCW, Wells DJ. Identification and Validation of Quantitative PCR Reference Genes Suitable for Normalizing Expression in Normal and Dystrophic Cell Culture Models of Myogenesis. PLoS Curr. 2014;6:1\u201323."},{"key":"1003_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3:1101\u20138.","journal-title":"Nat Protoc"},{"key":"1003_CR19","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.","journal-title":"Genome Biol"},{"key":"1003_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1023\/B:BILE.0000019559.84305.47","volume":"26","author":"MW Pfaffl","year":"2004","unstructured":"Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--excel-based tool using pair-wise correlations. Biotechnol Lett. 2004;26:509\u201315.","journal-title":"Biotechnol Lett"},{"key":"1003_CR21","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1093\/hmg\/ddn305","volume":"17","author":"A Masuda","year":"2008","unstructured":"Masuda A, Shen X-M, Ito M, Matsuura T, Engel AG, Ohno K. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet. 2008;17:4022\u201335.","journal-title":"Hum Mol Genet"},{"key":"1003_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2983630","volume":"7","author":"EC Fieller","year":"1940","unstructured":"Fieller EC. The biological standardization of insulin. Suppl to J R Stat Soc. 1940;7:1\u201364.","journal-title":"Suppl to J R Stat Soc"},{"key":"1003_CR23","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1093\/nar\/21.23.5463","volume":"21","author":"C MacLennan","year":"1993","unstructured":"MacLennan C, Beeson D, Vincent A, Newsom-Davis J. Human nicotinic acetylcholine receptor alpha-subunit isoforms: origins and expression. Nucleic Acids Res. 1993;21:5463\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1003_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1172\/JCI117302","volume":"94","author":"T Guyon","year":"1994","unstructured":"Guyon T, Levasseur P, Truffault F, Cottin C, Gaud C, Berrih-Aknin S. Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J Clin Invest. 1994;94:16\u201324.","journal-title":"J Clin Invest"},{"key":"1003_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/bioinformatics\/btn142","volume":"24","author":"JWK Ho","year":"2008","unstructured":"Ho JWK, Stefani M, Dos Remedios CG, Charleston MA. Differential variability analysis of gene expression and its application to human diseases. Bioinformatics. 2008;24:390\u20138.","journal-title":"Bioinformatics"},{"key":"1003_CR26","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1093\/bioinformatics\/bti722","volume":"21","author":"JK Choi","year":"2005","unstructured":"Choi JK, Yu U, Yoo OJ, Kim S. Differential coexpression analysis using microarray data and its application to human cancer. Bioinformatics. 2005;21:4348\u201355.","journal-title":"Bioinformatics"},{"key":"1003_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a008342","volume":"4","author":"CF Bentzinger","year":"2012","unstructured":"Bentzinger CF, Wang YX, M a R. Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect Biol. 2012;4:1\u201316.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1003_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/nyas.13522","volume":"1412","author":"JF Howard","year":"2018","unstructured":"Howard JF. Myasthenia gravis: the role of complement at the neuromuscular junction. Ann N Y Acad Sci. 2018;1412:113\u201328.","journal-title":"Ann N Y Acad Sci"},{"key":"1003_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.bbamem.2007.10.019","volume":"1778","author":"CE Gallegos","year":"2008","unstructured":"Gallegos CE, Pediconi MF, Barrantes FJ. Ceramides modulate cell-surface acetylcholine receptor levels. Biochim Biophys Acta. 2008;1778:917\u201330.","journal-title":"Biochim Biophys Acta"},{"key":"1003_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1365-2443.2004.00764.x","volume":"9","author":"M Yanagisawa","year":"2004","unstructured":"Yanagisawa M, Nakamura K, Taga T. Roles of lipid rafts in integrin-dependent adhesion and gp130 signalling pathway in mouse embryonic neural precursor cells. Genes Cells. 2004;9:801\u20139.","journal-title":"Genes Cells"},{"key":"1003_CR31","doi-asserted-by":"publisher","first-page":"22405","DOI":"10.1073\/pnas.0912336106","volume":"106","author":"Y Ohmi","year":"2009","unstructured":"Ohmi Y, Tajima O, Ohkawa Y, Mori A, Sugiura Y, Furukawa K, et al. Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues. PNAS. 2009;106:22405\u201310.","journal-title":"PNAS"},{"key":"1003_CR32","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1471-4159.2010.07067.x","volume":"116","author":"Y Ohmi","year":"2011","unstructured":"Ohmi Y, Tajima O, Ohkawa Y, Yamauchi Y, Sugiura Y, Furukawa K, et al. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. J Neurochem. 2011;116:926\u201335.","journal-title":"J Neurochem"},{"key":"1003_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-014-0179-6","volume":"3","author":"M Maurer","year":"2015","unstructured":"Maurer M, Bougoin S, Feferman T, Frenkian M, Bismuth J, Mouly V, et al. IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis. Acta Neuropathol Commun. 2015;3:1\u201314.","journal-title":"Acta Neuropathol Commun"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1003-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1003-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1003-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T20:41:23Z","timestamp":1580244083000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1003-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1003-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"20 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for this study was obtained from the University of Cape Town Health Sciences Faculty Research Ethics committee (REC 257\/2012) and all individuals (or their parents if <\u200918\u2009years) signed informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"24"}}